Predicted to enable SH3 domain binding activity. Predicted to be located in nuclear membrane and nucleoplasm. Predicted to be active in cytoplasm. Orthologous to human SH3BGRL2 (SH3 domain binding glutamate rich protein like 2).
RGD Description
Predicted to enable SH3 domain binding activity. Predicted to be located in nuclear membrane and nucleoplasm. Orthologous to human SH3BGRL2 (SH3 domain binding glutamate rich protein like 2); INTERACTS WITH 17beta-estradiol; 6-propyl-2-thiouracil; benzo[a]pyrene.